The Neuroendocrinology of Chronic Fatigue Syndrome

References

• I. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Scharberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387–9.
   Google Scholar
• Manu P, Lane Ti, Matthews DA. The frequency of chronic fatigue syndrome in patients with symptoms of persisting fatigue. Ann Intern Med 1988; 109: 554–6.
   PubMed Web of Science ®Google Scholar
• Katon W.1, Russo JE. Chronic fatigue syndrome criteria—A critique of the requirement for multiple physical symptoms. Arch Int Med 1992; 152: 1604–09.
   Google Scholar
• Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A and the International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: A comprehensive approach to its treatment and study. Ann Int Med 1994; 121:953–59.
   Google Scholar
• Demitrack MA, Greden JF. Chronic fatigue syndrome: the need for an inte-grative approach. Biol Psychiatry 1991; 30: 747–52.
   PubMed Web of Science ®Google Scholar
• Baxter JD, Tyrell JB. The adrenal cortex. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and Metabolism. New York: McGraw-Hill, 1981: 385–510.
   Google Scholar
• Charlton B, Ferrier I. Hypothalamic-pituitary-adrenal axis abnormalities in depression: a review and a model. Psychol Med 1989; 19: 331–36.
   PubMed Web of Science ®Google Scholar
• Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield Hi, May C, Post RM, Chrousos GP, Gold PW. Cerebrospinal fluid immunoreactive CRH and ACTH secretion in Cushing's disease and major depression: potential clinical implications..1Clin Endocrinol Metab 1991; 72: 260–71.
   PubMed Web of Science ®Google Scholar
• Kamilaris IC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN. Effect of altered thyroid function levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 1987; 65: 994–99.
   PubMed Web of Science ®Google Scholar
• Zeitoun MM, Hassan Al, Hussein ZM, Fahmy MS, Ragab M, Hussein M. Adrenal glucocorticoid function in acute viral infection in children. Acta Paediatr Scand 1973; 62: 608–14.
   PubMed Web of Science ®Google Scholar
• Preeyasombat C, Richards C, Silverman M, Kenny FM. Cortisol produc-tion. III Rubella and varicella encephalopathy, with a note on their treatment with steroids. Am J Dis Child 1965; 110: 370–3.
   Google Scholar
• McReynolds EW, Roy S. Diabetes insipidus secondary to group B beta streptococcal meningitis. J Tenn Med Assoc 1974; 117: 117–20.
   Google Scholar
• Hagg E, Astrom L, Steen L. Persistent hypothalamic- pituitary adrenal in-sufficiency following acute meningoencephalitis. Acta Med Scand 1978; 203: 231–5.
   Google Scholar
• Membreno L, Irony J, Dere W, Klein R, Biglieri EG, Cobb E. Adrenoconi-cal function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987; 65: 482–7.
   PubMed Web of Science ®Google Scholar
• Kupari M, Pelkonen R, Valtonen V. Post-encephalitic hypothalamic-pitu-itary insufficiency. Acta Endocrinol 1980; 94: 433–8.
   PubMedGoogle Scholar
• Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJP, Chrousos GP, Gold PW. Evidence for impaired activation of the Hypothalamic-pi-tuitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73: 1224–34.
   PubMed Web of Science ®Google Scholar
• Vale W, Speiss .J, Rivier C, Rivier J. Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and beta-en-dorphin. Science 1981; 213: 1394.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Khrishnan KRR. Neuroendocrine alterations in psychiatric dis-orders. In: Nemeroff CB, editor, Neuroendocrinology, 1992, CRC, Ann Arbor, MI.
   Google Scholar
• Nemeroff CB, Widerlov E, Bissett EG. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depression and schizo-phrenia. Science 1984; 226: 1342–4.
   Google Scholar
• Holsboer F, Gerken A, von Bardeleben U, Stalla GK, Muller OA. Blunted corticotropin and normal cortisol response to human corticotropin-releasing fac-tor in depression. N Engl J Med 1984; 311: 1127–37.
   Google Scholar
• Stokes PE, Pick GR, Stoll PM, Nunn WD. Pituitary adrenal function in de-pressed patients: resistance to dexamethasone suppression. J Psychiatr Res 1975; 12: 271–281.
   Web of Science ®Google Scholar
• Taerk GS, Toner BB, Salit 1E, Garfinkel PE, Ozersky S. Depression in pa-tients with neuromyasthenia (benign myalgic encephalomyalitis). Int J Psych Med 1987: 17:49–56.
   Google Scholar
• Hudson J1, Pliner LF, Hudson MF, Goldenberg DL, Melby JC. The dexa-methasone suppression test in fibrosis. Biol Psychiatry 1984; 19: 1489–93.
   PubMed Web of Science ®Google Scholar
• McCain GA, Tithe KS. Diurnal hormone variation in fibromyalgia syn-drome. J Rheumatol 1989 (Suppl.); 16: 154–7.
   Google Scholar
• Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. I Psychosom Res 1981; 25: 91–5.
   PubMed Web of Science ®Google Scholar
• Gilbert F, Braze11 C, Tricklebank MS, Stahl SM. Activation of the 5-11T IA receptor subtype increases rat plasma ACTH concentrations. Eur J Pharm 1988; 147: 431–7.
   Google Scholar
• Lesch KP, Sohnle K, Poten B, Rupprecht R, Schulte HM. Corticotropin and cortisol secretion following 5-hydroxytryptamine-I A receptor activation: Ef-fects of 5-HT receptor and beta-adrenoceptor antagonists. I Clin Endocrinol Me-tab 1990; 70: 670–4.
   Google Scholar
• Koenig J1, Meltzer HY, Gudelsky GA. 5-Hydroxytryptamine IA receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacology, Biochem-istry and Behaviour 1988; 29: 711–5.
   Google Scholar
• Dinan TG, Majeed T, Lavelle E, Berti C, Behan P. Serotonin-mediated ac-tivation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Submitted for publication.
   Google Scholar
• Molliver ME. Serotonergic neuronal systems: What their anatomic orga-nization tells us about function. .1 Clin Psychopharmacol 1987 (Suppl.); 7: 3–23.
   Google Scholar
• Dinan TG. Scrotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sciences. In Press.
   Google Scholar
• Yatham LN, Steiner L. Serotonin as a neuroendocrine modulator. Journal of Serotonin Research 1994; 1: 7–21.
   Google Scholar
• Bakheit AM, Behan PO, Dinan TG, Gray CE, O'Keane V. Possible upre-gulation of hypothalamic 5-HT receptors in patients with post-viral fatigue syn-drome. Brit Med J 1992; 304: 1010–2.
   Google Scholar
• Cleare A, Beam J, Allain T, McGregor A, Wessley S. Murray S. O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syn-drome. I Affective Disord 1995; 35: 283–9.
   Google Scholar
• Yatham LN, Morehouse RL, Chisholm BT, Haase DA, McDonald DD, Marrie T.J. Neuroendocrine assessment of serotonin function in chronic fatigue syndrome. Canad J Psych 1995; 40: 92–6.
   Google Scholar
• Beam J, Allain T, Coskeran P. Munro N, Butler J, McGregor A, Wessely S. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycaemia in chronic fatigue syndrome. Biol Psych 1995; 37: 245–52.
   Google Scholar
• Meltzer H, Lee H, Nash J. Effects of buspirone on prolactin secretion is not mediated by 5-1-1T IA receptor stimulation. Arch Gen Psych 1992; 42: 163.
   Google Scholar
• Perowtka S. Selective interaction of novel anxiolytics with 5-1-IT IA recep-tors. Biol Psych 1985; 20: 971–9.
   PubMed Web of Science ®Google Scholar
• Garatini S, Mennini T, Saminin R. From fentbramine racemate to d-fen-fluramine: specificity and potency of the effects on the serotonergic system and food intake. Ann NY Acad Sci 1987; 499: 156–6.
   Google Scholar
• Demitrack MA, Gold PW, Dale JK, Krahn DD, Kling MA, Straus SE. Plas-ma and cerebrospinal fluid metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psych 1992; 32: 1065–77.
   PubMed Web of Science ®Google Scholar
• Dieguez C, Page MD, Scanlon MF. Growth hormone neuroregulation and its alteration in disease states. Clin Endocrine' 1988; 28: 109–43.
   Google Scholar
• Casanueva FF, Burguera 8, Murals C, Dieguez C. Acute administration of corticoids: A new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 1990; 70: 234–37.
   Google Scholar
• Majeed T, Dinan TO, Thakore J, Gray C, Behan PO. Defective dexametha-sone induced growth hormone release in chronic fatigue syndrome: evidence for glucocorticoid receptor resistance and lack of plasticity? J Ir Coll Phys Surg 1995; 24: 20–4.
   Google Scholar
• Fish H, Chemow B, O'Brien J. Endocrine and neurophysiological re-sponses of the pituitary to insulin induced hypoglycemia: A review. Metabolism; 35: 763–80.
   Google Scholar
• Selye H. Stress without distress. Philadelphia, PA 1974; Lippincott.
   Google Scholar
• Michelson D, Licinio J, Gold PW. Mediation of the stress response by the hypothalamic-pituitary-adrenal axis. In: Friedman MJ, Charncy DS, Deutch AY, eds. Neurobiological and clinical consequences of stress: From normal adaptation to PTSD. Philadelphia: Lippincott-Raven Publishers, 1995: 225–38.
   Google Scholar
• Calogero AE, Gallucci WT, Chrousos GP, et al. Catecholamine effects upon rat hypothalamic corticotropin releasing hormone secretion in vitro. J Clin Invest 1988; 82: 839–846.
   PubMed Web of Science ®Google Scholar
• Calogero AE, Bemardini R, Margioris AN, et al. Effects of serotonergic agonists and antagonists on corticotropin releasing hormone secretion by ex-planted rat hypothalami. Peptides 1989; 10: 189–200.
   PubMed Web of Science ®Google Scholar
• Calogero AE, Gallucci WT, Bernardini R, et at. Effects of cholinergic ago-nists and antagonists on rat hypothalamic corticotropin releasing hormone secre-tion in vitro. Neuroendocrinology 1988; 47: 303–8.
   PubMed Web of Science ®Google Scholar
• Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stim-ulates the secretion of hypothalamic corticotropin releasing factor. Science 1987; 238: 522–4.
   Google Scholar
• Naitoh Y, Fukata .J, Toiminaga T, Naki Y, Tami S. Mori K, Imura H. Inter-leukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious free-moving rats. Biochem Biophy Res Commun 1988; 155: 1459–1463.
   Google Scholar
• McEwen BS, Davis PG, Parsons B, Pfaff DW. The brain as a target for ste-roid hormone action. Ann Rev Neurosci 1979; 2: 65–112.
   PubMed Web of Science ®Google Scholar
• Reul JM, DeKloet ER. Anatomical sites of resolution of two types of corti-costerone receptors in the rat brain with in vitro autoradiography and computer-ized image analysis. J Steroid Biochem 1986; 24: 269–72.
   PubMedGoogle Scholar
• Scbildkraut JJ. The catecholamine hypothesis of affective disorders: a re-view of supporting evidence. Am .1 Psych 1965; 122: 509–22.
   PubMed Web of Science ®Google Scholar
• DeKloet ER, Sybesma H, Reul JM H. Selective control by corticosterone of serotonin- I receptor capacity in raphe-hippocampal system. Neuroendocrinology 1986; 42: 513–22.
   Google Scholar
• Thakore .1H, Dinan TO. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychia-try 1995; 37: 364–368.
   Google Scholar